- Home
- PROK vs ERH Comparison
PROK vs ERH Comparison
Compare PROK & ERH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- ERH
- Stock Information
- Founded
- PROK 2015
- ERH 2004
- Country
- PROK United States
- ERH United States
- Employees
- PROK N/A
- ERH N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- ERH Finance/Investors Services
- Sector
- PROK Health Care
- ERH Finance
- Exchange
- PROK Nasdaq
- ERH Nasdaq
- Market Cap
- PROK 94.9M
- ERH 97.6M
- IPO Year
- PROK N/A
- ERH N/A
- Fundamental
- Price
- PROK $0.81
- ERH $11.25
- Analyst Decision
- PROK Buy
- ERH
- Analyst Count
- PROK 4
- ERH 0
- Target Price
- PROK $5.00
- ERH N/A
- AVG Volume (30 Days)
- PROK 796.9K
- ERH 23.2K
- Earning Date
- PROK 05-12-2025
- ERH 01-01-0001
- Dividend Yield
- PROK N/A
- ERH 8.85%
- EPS Growth
- PROK N/A
- ERH N/A
- EPS
- PROK N/A
- ERH N/A
- Revenue
- PROK $306,000.00
- ERH N/A
- Revenue This Year
- PROK N/A
- ERH N/A
- Revenue Next Year
- PROK N/A
- ERH N/A
- P/E Ratio
- PROK N/A
- ERH N/A
- Revenue Growth
- PROK N/A
- ERH N/A
- 52 Week Low
- PROK $0.46
- ERH $7.97
- 52 Week High
- PROK $4.44
- ERH $10.91
- Technical
- Relative Strength Index (RSI)
- PROK 49.17
- ERH 65.18
- Support Level
- PROK $0.94
- ERH $10.92
- Resistance Level
- PROK $0.87
- ERH $11.28
- Average True Range (ATR)
- PROK 0.11
- ERH 0.18
- MACD
- PROK 0.01
- ERH 0.03
- Stochastic Oscillator
- PROK 39.10
- ERH 93.24
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About ERH Allspring Utilities and High Income Fund
Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.